K980646 is an FDA 510(k) clearance for the IL SYNTHESIS--ADDITION OF BILIRUBIN AS A MEASURED PARAMETER FOR NEONATE WHOLE BLOOD SAMPLES. This device is classified as a Bilirubin (total And Unbound) In The Neonate Test System (Class I - General Controls, product code MQM).
Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on May 6, 1998, 76 days after receiving the submission on February 19, 1998.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1113.